Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Thiogenesis Therapeutics Corp TTIPF


Primary Symbol: V.TTI

Thiogenesis Therapeutics, Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is developing sulfur-containing prodrugs that act as precursors with the potential to treat serious pediatric diseases with unmet medical needs. The Company’s lead compound, TTI-0102, is a disulfide, made up of two thiols that lead to two independent cysteamine molecules. Cysteamine is a... see more

Bullboard (TSXV:TTI)

View:
User Avatar Image
(95)
•••
  • MarketMakerssX
Post by MarketMakersson Feb 14, 2025 1:01pm

New OCTQX Best Market Listing

NEW OTCQX BEST MARKET LISTING - Thiogenesis Therapeutics (TTI.v TTIPF: https://x.com/StckMasterFlash/status/1889732437858771156   As a clinical-stage biotechnology company targeting ...more  
User Avatar Image

•••
  • Jonathon BrownX
Post by Jonathon Brownon Feb 13, 2025 9:16am

Buzz on the Bullboards: Despite tariffs, Bombardier flying high

User Avatar Image
(95)
•••
  • MarketMakerssX
Post by MarketMakersson Feb 12, 2025 12:36pm

TTI Commences Trading on OTCQX in US

TODAY: Thiogenesis Therapeutics (TTI.v TTIPF) Commences OTCQX Trading in the US   Today, Thiogenesis Therapeutics (TTI.v TTIPF) announced that its common shares are now trading on the OTCQX ...more  
User Avatar Image
(134)
•••
  • 1StockInformerX
Post by 1StockInformeron Jan 31, 2025 7:37pm

TTI.v: Advancing Phase II Trials in 2025 (DD + Recent News)

Thiogenesis Therapeutics Corp. (Ticker: TTI.v or TTIPF for US investors), a clinical-stage biopharmaceutical company developing thiol-active therapeutics for mitochondrial diseases, is preparing to ...more  
User Avatar Image
(95)
•••
  • MarketMakerssX
Post by MarketMakersson Jan 27, 2025 3:27pm

Final EU Clearance to Initiate Phase 2 MELAS Trials Received

Thiogenesis Therapeutics (TTI.v) Receives Final EU Clearance of CTA to Initiate Phase 2 Clinical Trial in MELAS   Today, Thiogenesis Therapeutics (TTI.v) announced that the European Medicines ...more  
User Avatar Image
(95)
•••
  • MarketMakerssX
Post by MarketMakersson Jan 23, 2025 4:03pm

High-Growth Biotech Opportunity

A High-Growth Biotech Opportunity - Thiogenesis Therapeutics (TTI.v) Thiogenesis Therapeutics (TTI.v) is a clinical-stage biotech company specializing in thiol-active compounds to treat mitochondrial ...more  
User Avatar Image
(95)
•••
  • MarketMakerssX
Post by MarketMakersson Jan 17, 2025 4:06pm

Key Mechanisms for TTI's Lead Product

Key Mechanisms for Thiogenesis Therapeutics' (TTI.v) Lead Product Targeting Unmet Medical Needs   Capitalizing on a $9.8 billion market opportunity within the global rare disease and ...more  
User Avatar Image
(95)
•••
  • MarketMakerssX
Post by MarketMakersson Jan 10, 2025 4:11pm

Unlocking Rare Disease Potential

Unlocking Rare Disease Potential: Why Thiogenesis Therapeutics (TTI.v) Could Be a Game-Changer Interested in a unique opportunity in biotech space? Check out Thiogenesis Therapeutics (TTI.v), a ...more  
User Avatar Image
(134)
•••
  • 1StockInformerX
Post by 1StockInformeron Jan 09, 2025 7:44pm

TTI Advances Lead Drug Targeting Pediatric & Orphan Diseases

A mid-December financial analysis from Valuation Lab highlights the significant potential of Thiogenesis Therapeutics' (Ticker: TTI.v or TTIPF for US investors) lead compound, TTI-0102, and its ...more  
User Avatar Image
(1)
•••
  • SkywalkerofLukeX
Post by SkywalkerofLukeon Jan 08, 2025 3:42pm

Informative Post on Thiogenesis

Recommend this post on Thiogenesis Therapeutics Corp. (TTI.v TTIPF) and the development of the drug TTI-0102 which is designed to treat pediatric NASH by releasing cysteamine, a potent antioxidant ...more  
User Avatar Image
(134)
•••
  • 1StockInformerX
Post by 1StockInformeron Jan 07, 2025 7:32pm

TTI Targets Multi-Billion Dollar Markets, Advancing Trials

Thiogenesis Therapeutics Corp. (Ticker: TTI.v) is a clinical-stage biopharmaceutical company focused on developing thiol-active therapeutic compounds to address mitochondrial dysfunctions with high ...more  
User Avatar Image
(95)
•••
  • MarketMakerssX
Post by MarketMakersson Jan 03, 2025 5:05pm

Groundbreaking BioChem Opportunity

Offering a groundbreaking investment opportunity with a projected upside of 1130%, Thiogenesis Therapeutics (TTI.v) is driven by its innovative thiol-active compounds targeting rare mitochondrial ...more  
User Avatar Image
(1)
•••
  • SkywalkerofLukeX
Post by SkywalkerofLukeon Jan 02, 2025 5:48pm

Good Recap on Thiogenesis

Good recap of Thiogenesis Therapeutics Corp. (TTI.v TTIPF) and the development of the drug TTI-0102 which is designed to treat pediatric NASH by releasing cysteamine, a potent antioxidant that can ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities